Polyhydramnios

Jump to: navigation, search

For patient information, click here

Polyhydramnios
ICD-10 O40
ICD-9 657
DiseasesDB 10319
MedlinePlus 003267
MeSH D006831

WikiDoc Resources for Polyhydramnios

Articles

Most recent articles on Polyhydramnios

Most cited articles on Polyhydramnios

Review articles on Polyhydramnios

Articles on Polyhydramnios in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Polyhydramnios

Images of Polyhydramnios

Photos of Polyhydramnios

Podcasts & MP3s on Polyhydramnios

Videos on Polyhydramnios

Evidence Based Medicine

Cochrane Collaboration on Polyhydramnios

Bandolier on Polyhydramnios

TRIP on Polyhydramnios

Clinical Trials

Ongoing Trials on Polyhydramnios at Clinical Trials.gov

Trial results on Polyhydramnios

Clinical Trials on Polyhydramnios at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Polyhydramnios

NICE Guidance on Polyhydramnios

NHS PRODIGY Guidance

FDA on Polyhydramnios

CDC on Polyhydramnios

Books

Books on Polyhydramnios

News

Polyhydramnios in the news

Be alerted to news on Polyhydramnios

News trends on Polyhydramnios

Commentary

Blogs on Polyhydramnios

Definitions

Definitions of Polyhydramnios

Patient Resources / Community

Patient resources on Polyhydramnios

Discussion groups on Polyhydramnios

Patient Handouts on Polyhydramnios

Directions to Hospitals Treating Polyhydramnios

Risk calculators and risk factors for Polyhydramnios

Healthcare Provider Resources

Symptoms of Polyhydramnios

Causes & Risk Factors for Polyhydramnios

Diagnostic studies for Polyhydramnios

Treatment of Polyhydramnios

Continuing Medical Education (CME)

CME Programs on Polyhydramnios

International

Polyhydramnios en Espanol

Polyhydramnios en Francais

Business

Polyhydramnios in the Marketplace

Patents on Polyhydramnios

Experimental / Informatics

List of terms related to Polyhydramnios

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Polyhydramnios (polyhydramnion, hydramnios) is the medical condition of too much amniotic fluid in the amniotic sac. It is seen in 0.5 to 2% of pregnancies.

The opposite to Polyhydramnios is Oligohydramnios. This is a deficiency in amniotic fluid. It is very rare.

Etiology

Polyhydramnios is generally due to maternal diabetes (around 20% of cases) and results from hyperglycemia of the fetus which results in fetal polyuria (fetal urine is a major source of amniotic fluid). About 20% of the cases of polyhydramnios are associated with fetal anomalies that impairs the ability of the fetus to swallow (because the fetus normally swallows amniotic fluid and absorbs it through its intestinal villi). This includes:

In a multiple gestation pregnancy, twin-twin transfusion syndrome is usually the cause.

Associated conditions

Fetuses with polyhydramnios are at risk for a number of other problems including cord prolapse, placental abruption and perinatal death. At delivery the baby should be checked for congenital abnormalities.

Treatment

In some cases, amnioreduction has been used in response to polyhydramnios.[1]

References

  1. Piantelli G, Bedocchi L, Cavicchioni O; et al. (2004). "Amnioreduction for treatment of severe polyhydramnios". Acta bio-medica : Atenei Parmensis. 75 Suppl 1: 56–8. PMID 15301292.

Cost Effectiveness of Polyhydramnios

| group5 = Clinical Trials Involving Polyhydramnios | list5 = Ongoing Trials on Polyhydramnios at Clinical Trials.govTrial results on PolyhydramniosClinical Trials on Polyhydramnios at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Polyhydramnios | list6 = US National Guidelines Clearinghouse on PolyhydramniosNICE Guidance on PolyhydramniosNHS PRODIGY GuidanceFDA on PolyhydramniosCDC on Polyhydramnios


| group7 = Textbook Information on Polyhydramnios | list7 = Books and Textbook Information on Polyhydramnios


| group8 = Pharmacology Resources on Polyhydramnios | list8 = AND (Dose)}} Dosing of PolyhydramniosAND (drug interactions)}} Drug interactions with PolyhydramniosAND (side effects)}} Side effects of PolyhydramniosAND (Allergy)}} Allergic reactions to PolyhydramniosAND (overdose)}} Overdose information on PolyhydramniosAND (carcinogenicity)}} Carcinogenicity information on PolyhydramniosAND (pregnancy)}} Polyhydramnios in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Polyhydramnios


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Polyhydramnios | list9 = AND (pharmacogenomics)}} Genetics of PolyhydramniosAND (pharmacogenomics)}} Pharmacogenomics of PolyhydramniosAND (proteomics)}} Proteomics of Polyhydramnios


| group10 = Newstories on Polyhydramnios | list10 = Polyhydramnios in the newsBe alerted to news on PolyhydramniosNews trends on Polyhydramnios


| group11 = Commentary on Polyhydramnios | list11 = Blogs on Polyhydramnios

| group12 = Patient Resources on Polyhydramnios | list12 = Patient resources on PolyhydramniosDiscussion groups on PolyhydramniosPatient Handouts on PolyhydramniosDirections to Hospitals Treating PolyhydramniosRisk calculators and risk factors for Polyhydramnios


| group13 = Healthcare Provider Resources on Polyhydramnios | list13 = Symptoms of PolyhydramniosCauses & Risk Factors for PolyhydramniosDiagnostic studies for PolyhydramniosTreatment of Polyhydramnios

| group14 = Continuing Medical Education (CME) Programs on Polyhydramnios | list14 = CME Programs on Polyhydramnios

| group15 = International Resources on Polyhydramnios | list15 = Polyhydramnios en EspanolPolyhydramnios en Francais

| group16 = Business Resources on Polyhydramnios | list16 = Polyhydramnios in the MarketplacePatents on Polyhydramnios

| group17 = Informatics Resources on Polyhydramnios | list17 = List of terms related to Polyhydramnios


}}

de:Polyhydramnion nl:Polyhydramnion


Linked-in.jpg